Enable Injections Names Timothy R. Flaherty VP & CFO

FRANKLIN, Ohio, Feb. 11, 2015 /PRNewswire/ -- Enable Injections, developer of a new class of body-worn injection technology that may soon make it easy and comfortable for patients to self-inject large volume, high viscosity drugs in the comfort of their homes, has named Timothy R. Flaherty as Vice President and Chief Financial Officer.

He was most recently CFO for North America of privately held Bonfiglioli, a global power transmission equipment manufacturer.  Prior to that, he served as a financial executive at publicly held Arvinmeritor, Ametek/HCC Industries and AtriCure. 

"Tim's extensive experience provides Enable Injections with the additional expertise and leadership our company will need to fuel our growth," says President & CEO Michael D. Hooven.  "It complements both our operations and long-term objectives."

In his new role, Flaherty will oversee finance, accounting, and information technology and play a key role in business development and strategy.

About Enable Injections

Enable Injections develops and manufactures devices that allow easy, comfortable patient self-administration of biologic and other high volume, high viscosity drugs*. The Enable body-worn Injector utilizes any standard container closure system, including syringe, vial or cartridge.  It automatically warms the drug, and can automatically mix lyophilized solutions.  Founded February 2010 by medical device industry veterans, the company has administrative, R&D and manufacturing facilities in Franklin, Ohio.  Please visit www.enableinjections.com.

*Available for investigational use only

SOURCE Enable Injections

Related Links

http://www.enableinjections.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED